Chugai Pharmaceuticals to invest $355m by 2021 in Singapore R&D

Chugai Pharmaceuticals to invest $355m by 2021 in Singapore R&D

Brand image from the company website

Japan’s Chugai Pharmaceuticalwhich operates satellite labs throughout Asia, has plans to invest $355 million by 2021, to ramp up and accelerate its research and development (R&D) capabilities in Singapore.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter